IDEC Pharmaceuticals

111In-Ibritumomab tiuxetan, commercially known as 111In-Zevalin, was developed by IDEC Pharmaceuticals as a diagnostic imaging agent to facilitate the selection of patients suitable for treatment… Read More »111In-Ibritumomab Tiuxetan